Yamamoto Shingo | 論文著者

Dept. of Chemical Engineering, Tokyo University of Agriculture and Technology

Division of Cardiology, Saitama Medical Center, Jichi Medical University

Faculty of Engineering, Shizuoka University, Hamamatsu 432-8561, Japan

Graduate School Of Pharmaceutical Sciences Tokyo University Of Science

Graduate School of Pharmaceutical Sciences, Tokyo University of Science

Hyogo College of Medicine

Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.Hochfeld-Magnetlabor Dresden (HLD-EMFL), Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.

Japanese UTI Research Group

Kyoto University Hospital, Department of Urology

Laboratory for Chemistry, Institute for Life Science Research, Asahi Chemical Industry Co., Ltd.

The Department Of Urology Hyogo College Of Medicine

The Department of Urology, Hyogo College of Medicine

University of Alabama at Birmingham, Immunology Vaccine Center

Urogenital Sub-committee and the Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and The Japanese Society for Clinical Microbiology (JSCM)

Uti Subcommittee Of The Clinical Evaluation Guidelines Committee Japan Society Of Chemotherapy

UTI Subcommittee of the Clinical Evaluation Guidelines Committee, Japan Society of Chemotherapy

兵庫医科大学 泌尿器科

兵庫医科大学 泌尿器科学